ATG5 and asthma: ATG5 was increased in adult asthma patients at exacerbation compared to adult asthma patients at remission [median (IQR): 53.6 (37.6–90.0) vs. 35.6 (28.2–51.5) ng/mL] (P < 0.001) (Fig. 5A).